Postpartum Depression: Medication vs. Therapy — What the Research Says

The Question Every Parent with PPD Asks

When you are diagnosed with postpartum depression, one of the first decisions you face is how to treat it. Should you try therapy? Medication? Both? And if you are breastfeeding, is medication even safe?

These questions carry more weight during the postpartum period than at almost any other time in life. You are making decisions not only for yourself but for your baby. You may be breastfeeding. You are sleep-deprived and struggling to think clearly. And the pressure to "just push through" without medication is intense — fueled by stigma, misinformation, and the cultural expectation that new parenthood should feel natural and joyful.

Here is what the evidence actually says.

80%

Source: Postpartum Support International

Therapy for Postpartum Depression

What the Research Supports

Two therapies have the strongest evidence for PPD specifically:

Interpersonal Therapy (IPT): IPT is considered a first-line treatment for postpartum depression. It targets the interpersonal disruptions that fuel PPD — the role transition to parenthood, partner conflict, social isolation, and grief over your pre-baby life. Multiple randomized controlled trials have found IPT as effective as antidepressants for mild to moderate PPD.

Cognitive Behavioral Therapy (CBT): CBT addresses the negative thought patterns that characterize PPD — guilt, self-blame, catastrophizing, perfectionism — and builds practical coping skills. CBT adapted for the perinatal period has demonstrated effectiveness in both preventing and treating PPD.

For a full comparison of therapy options, see our guide to the best therapy for postpartum depression.

When Therapy Alone May Be Sufficient

Clinical guidelines generally support therapy as a standalone treatment for mild to moderate postpartum depression. Therapy alone may be the right choice if:

• Your symptoms are interfering with your quality of life but not severely impairing your daily functioning
• You are able to care for your baby and yourself, even if it feels harder than it should
• You have a strong preference for non-medication treatment
• You are breastfeeding and want to avoid any medication exposure (though this alone is not a reason to avoid medication when it is needed — see below)
• You have access to a therapist with perinatal experience

“

For mild to moderate postpartum depression, therapy is not a compromise — it is a first-line treatment with outcomes that rival medication, plus the benefit of teaching skills that protect against future episodes.

Medication for Postpartum Depression

SSRIs: The First-Line Medication

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medications for PPD. They work by increasing serotonin availability in the brain, which helps regulate mood, anxiety, and sleep.

Sertraline (Zoloft) is typically the first SSRI recommended for breastfeeding mothers because it transfers into breast milk in very small amounts. Studies have found that infant serum levels of sertraline are generally undetectable or clinically insignificant. Paroxetine (Paxil) is another SSRI with low breast milk transfer and a strong safety profile during nursing.

SSRIs typically take 2 to 4 weeks to reach full effectiveness, with some improvement often noticeable within the first 1 to 2 weeks. Treatment is usually recommended for 6 to 12 months, with gradual tapering under medical supervision.

Addressing the Breastfeeding Fear

The fear of harming your baby through breastmilk medication exposure is one of the most common reasons parents avoid or delay treatment for PPD. This fear is understandable but often based on outdated information or misinformation.

Here is what the evidence shows:

• Several SSRIs have been extensively studied during breastfeeding and are considered compatible with nursing by the American Academy of Pediatrics and other major medical organizations
• The amount of medication that reaches the infant through breast milk is extremely small — typically less than 10 percent of the maternal dose, and often much less
• Untreated depression also carries risks for your baby. Research consistently shows that maternal depression affects infant bonding, development, and well-being. The risk of untreated PPD must be weighed against the very low risk of medication exposure through breast milk
• You do not have to choose between treating your depression and breastfeeding. For most parents, both are possible simultaneously

New Medications Specifically for PPD

In recent years, two groundbreaking medications have been developed specifically for postpartum depression, offering new options for parents who do not respond to traditional treatments:

Brexanolone (Zulresso): Approved by the FDA in 2019, brexanolone was the first medication developed specifically for PPD. It is a synthetic form of allopregnanolone, a neurosteroid that drops dramatically after delivery. Brexanolone is administered as a continuous 60-hour IV infusion in a certified healthcare facility. Clinical trials showed rapid improvement — many patients experienced significant relief within 24 to 48 hours. However, its use is limited by the requirement for inpatient administration and its cost.

Zuranolone (Zurzuvae): Approved by the FDA in 2023, zuranolone is the first oral medication specifically for PPD. It is taken once daily for just 14 days, and clinical trials showed significant improvement in depressive symptoms as early as day 3. Zuranolone works through a similar mechanism as brexanolone, targeting GABA-A receptors. Its oral formulation and short treatment course make it more accessible, though it is not recommended during breastfeeding without discussing risks and benefits with a provider.

Day 3

Source: FDA clinical trial data

Therapy vs. Medication: A Direct Comparison

When Combined Treatment Is Recommended

For moderate to severe postpartum depression, the combination of therapy and medication is the gold standard. Research consistently shows that combined treatment produces:

• Faster initial improvement than either treatment alone
• Greater overall symptom reduction at the end of treatment
• Lower relapse rates than medication alone
• Better functional outcomes — the ability to care for yourself, your baby, and your relationships

Combined treatment is particularly recommended when:

• Symptoms are severe or include suicidal thoughts
• PPD significantly impairs your ability to care for your baby
• You have a history of severe or recurrent depression
• Therapy alone has not produced sufficient improvement after 4 to 6 weeks
• Symptoms include psychotic features (this requires immediate psychiatric care)

How to Decide: A Practical Framework

There is no single right answer, and the best approach depends on your specific situation. Here is a framework for thinking through your options:

Consider therapy alone if:

• Your PPD is mild to moderate
• You have strong preference against medication
• You have access to a therapist experienced with perinatal populations
• You want skills that protect against future episodes

Consider medication (with or without therapy) if:

• Your symptoms are moderate to severe
• You are unable to function in daily life or care for your baby
• You have a biological vulnerability (family history of depression, previous severe episodes)
• Therapy alone has not produced sufficient improvement

Consider combined treatment if:

• Your depression is moderate to severe
• You want the fastest, most thorough recovery
• You have a history of recurrent depression
• You want both symptom relief and long-term skills

Ask your provider about brexanolone or zuranolone if:

• Standard SSRIs have not worked
• You need rapid symptom relief
• Your PPD is severe or treatment-resistant

What About "Natural" Alternatives?

Parents with PPD often ask about alternatives to therapy and medication — exercise, supplements, light therapy, omega-3 fatty acids, or herbal remedies. While some of these have modest evidence as complementary approaches (moderate exercise, in particular, has demonstrated antidepressant effects in postpartum populations), none has sufficient evidence to be recommended as a primary treatment for clinical postpartum depression.

If your symptoms meet the criteria for PPD — if they are persistent, intense, and impairing your functioning — evidence-based treatment (therapy, medication, or both) should be the foundation of your recovery plan. Complementary approaches can be added alongside, not instead of, proven treatments.

The Bottom Line

You do not have to choose between being a good parent and treating your depression. Therapy works. Medication is safe for most breastfeeding parents. Combined treatment offers the strongest outcomes for moderate to severe PPD. And newer medications like zuranolone are expanding options for parents who need rapid relief.

The most important decision is not which treatment to choose — it is the decision to seek treatment at all. If PPD is affecting your relationships or your daily life, help is available, effective, and within reach.

Get the Support You Deserve

Whether you choose therapy, medication, or both — the most important step is reaching out. A qualified provider can help you find the right approach for your situation.

Find a Therapist